Joycelynne Palmer is Biostatistics Core Director for the Hematologic Malignancies and Stem Cell Transplantation Institute; she provides scientific oversight and statistical support (design, monitoring, analysis and reporting) for the Biostatistics Core and all hematology related programs. She has research interest and effort support pre-clinical and clinical studies concerning the major obstacles to disease control/cure of hematologic malignancies and successful hematopoietic stem cell transplantation (HSCT). In 2005, she was named the Co-Core Director of the Biostatistics Core for the Lymphoma SPORE and Hematology/HCT Program Project Grants. In addition, she support the CMV and HIV/AIDS laboratories working on translational research in designing and analyzing pre-clinical studies and early phase gene transfer clinical trials. She work also supports the Radio immunotherapy and Cancer Immunotherapeutic laboratories, designing earlier (phase I/II) and later phase (phase III) radio immunotherapy-based clinical trials and early phase STAT3 clinical trials where the targeting of STAT3 is used to improve immunotherapy. She is collaborating investigator/named Senior Biostatistician on our first-in-human phase I CpG-STAT3 siRNA trials, first-in-human phase I small molecule studies in acute leukemia, and our phase I studies of TMLI-based HSCT in acute leukemia, multiple myeloma and lymphoma. She also serve on the Data and Safety Monitoring Committee and the Institutional Review B.
Other Editorial Board Members
Shireen Hamid Farhan
Institute for Genetic Engineering and Biotechnologies
View Profile
Sandeep Kumar Kar
Institute of Postgraduate Medical Education and Research
View Profile
Chat with us on WhatsApp
